Every investor in Shandong Sino-Agri United Biotechnology Co.,Ltd (SZSE:003042) should be aware of the most powerful shareholder groups. We can see that private companies own the lion's share in the company with 48% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
As a result, private companies were the biggest beneficiaries of last week's 21% gain.
Let's take a closer look to see what the different types of shareholders can tell us about Shandong Sino-Agri United BiotechnologyLtd.
See our latest analysis for Shandong Sino-Agri United BiotechnologyLtd
SZSE:003042 Ownership Breakdown October 31st 2022
What Does The Institutional Ownership Tell Us About Shandong Sino-Agri United BiotechnologyLtd?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
Shandong Sino-Agri United BiotechnologyLtd already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Shandong Sino-Agri United BiotechnologyLtd's earnings history below. Of course, the future is what really matters.
SZSE:003042 Earnings and Revenue Growth October 31st 2022
We note that hedge funds don't have a meaningful investment in Shandong Sino-Agri United BiotechnologyLtd. Our data shows that CNAMPGC Shanghai Corporation is the largest shareholder with 31% of shares outstanding. In comparison, the second and third largest shareholders hold about 9.6% and 8.6% of the stock. Xu Hui, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer.
To make our study more interesting, we found that the top 4 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.
Insider Ownership Of Shandong Sino-Agri United BiotechnologyLtd
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
Our most recent data indicates that insiders own a reasonable proportion of Shandong Sino-Agri United Biotechnology Co.,Ltd. Insiders have a CN¥366m stake in this CN¥2.8b business. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.
General Public Ownership
The general public-- including retail investors -- own 30% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
Private Company Ownership
It seems that Private Companies own 48%, of the Shandong Sino-Agri United BiotechnologyLtd stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
Next Steps:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - Shandong Sino-Agri United BiotechnologyLtd has 2 warning signs (and 1 which can't be ignored) we think you should know about.
If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
山东中农联合生物科技股份有限公司(深交所股票代码:003042)的每一位投资者都应该知道最强大的股东群体。我们可以看到,私营公司以48%的所有权拥有该公司的最大份额。换句话说,该集团面临着最大的上行潜力(或下行风险)。
因此,私营企业是上周21%涨幅的最大受益者。
让我们仔细看看不同类型的股东对山东中农联合生物技术有限公司有什么启示。
查看我们对山东中农联合生物技术有限公司的最新分析
深圳证交所:003042股权结构2022年10月31日
关于山东中农联合生物技术有限公司,机构持股告诉了我们什么?
机构投资者通常将自己的回报与经常跟踪的指数的回报进行比较。因此,他们通常确实会考虑收购被纳入相关基准指数的较大公司。
山东中农联合生物科技有限公司已在股份登记处登记了机构。事实上,他们在该公司拥有可观的股份。这可以表明该公司在投资界具有一定的公信力。然而,最好警惕依赖机构投资者带来的所谓验证。他们也一样,有时也会犯错。如果多家机构同时改变对一只股票的看法,你可能会看到股价迅速下跌。因此,以下是山东中农联合生物技术有限公司的盈利历史,值得一看。当然,未来才是真正重要的。
深圳证交所:003042收益和收入增长2022年10月31日
我们注意到,对冲基金在山东中农联合生物技术有限公司没有有意义的投资。我们的数据显示,CNAMPGC上海公司是第一大股东,持有31%的流通股。相比之下,第二大和第三大股东分别持有约9.6%和8.6%的股份。第二大股东许辉也恰好持有首席执行官的头衔。
为了让我们的研究更有趣,我们发现前四大股东控制着公司一半以上的股份,这意味着这个群体对公司的决策有相当大的影响力。
虽然研究一家公司的机构持股可以增加你的研究价值,但研究分析师的建议以更深入地了解一只股票的预期表现也是一个很好的做法。目前,我们没有注意到分析师对该股的报道,因此该公司不太可能被广泛持有。
山东中农联合生物技术有限公司的内部人持股
尽管对内部人的准确定义可能是主观的,但几乎每个人都认为董事会成员是内部人。公司管理层对董事会负责,董事会应代表股东的利益。值得注意的是,有时最高层管理人员本身也是董事会成员。
我通常认为内部人持股是一件好事。然而,在某些情况下,这会让其他股东更难让董事会对决策负责。
我们的最新数据显示,内部人士持有山东中农联合生物技术有限公司相当比例的股份。内部人士在这笔28亿元人民币的业务中持有3.66亿元人民币的股份。看到内部人士如此投资于这项业务,真是太好了。或许值得一查的是,这些内部人士最近是否一直在买入。
一般公有制
包括散户投资者在内的普通公众持有该公司30%的股份,因此不能轻易忽视。尽管这种规模的所有权可能不足以影响有利于他们的政策决定,但他们仍然可以对公司政策产生集体影响。
私营公司所有权
民营企业似乎拥有山东中农联合生物技术有限公司48%的股份。或许有必要对此进行更深入的研究。如果关联方,如内部人士,对这些私营公司中的一家有利害关系,则应在年报中披露。私营公司也可能对该公司拥有战略利益。
接下来的步骤:
我发现看看到底是谁拥有一家公司是非常有趣的。但为了真正获得洞察力,我们还需要考虑其他信息。以风险为例-山东中农联合生物技术有限公司2个警告标志(还有一个不容忽视)我们认为你应该知道这一点。
如果你更愿意看看另一家公司--一家财务状况可能更好的公司--那么不要错过这一点免费令人感兴趣的公司名单,有强劲的财务数据支持。
注:本文中的数字是使用过去12个月的数据计算的,指的是截至财务报表日期的最后一个月的12个月期间。这可能与全年的年度报告数字不一致。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。